Executive Summary
Haw Par is a rare "hidden asset" play: the company's investment portfolio (primarily UOB shares worth S$2.13B) plus cash nearly equals its market cap, meaning investors get Tiger Balm for free. However, this NAV discount has persisted for decades due to Wee family cross-holdings - a classic value trap.
Financial Summary (2024)
| Metric | Value | Assessment |
|---|---|---|
| Revenue | S$245M | +5.5% YoY |
| Net Income | S$228M | +5.4% YoY |
| Dividend Yield | 3.59% | Moderate |
| Payout Ratio | 38.79% | Conservative |
| Net Cash/Share | S$3.31 | Strong |
| P/E | 14x | Attractive |
| 1Y Return | +36% | Bank rally effect |
Hidden Asset Breakdown (Key Research Finding)
| Asset | Value | Per Share |
|---|---|---|
| UOB Shares | S$2.13B | ~S$9.60 |
| UOL Shares | ~S$470M | ~S$2.10 |
| Net Cash | S$732M | S$3.31 |
| Total Portfolio + Cash | ~S$3.3B | ~S$15.00 |
| Current Market Cap | S$3.5B | S$15.18 |
| Implied Tiger Balm Value | S$0.2B | S$0.18 |
The market is essentially giving you Tiger Balm for free.
Tiger Balm is sold in 100+ countries with 100+ year heritage. The brand alone is conservatively worth S$0.5-1.0B.
Moat Assessment: NARROW MOAT
Tiger Balm Brand
- 100+ year heritage (established 1870s)
- Sold in 100+ countries
- Dominant in Asian markets
- Simple, defensible product (ointment formulation)
- Strong brand recognition with older demographics
Investment Holdings
- Wee family cross-holdings (UOB, UOL, Haw Par)
- Dividend income provides stable cash flow
- No catalyst to unlock value - family controls all entities
Moat Durability: 10+ Years
Tiger Balm brand will endure, but growth is limited.
The Value Trap Question
Why the discount persists:
- Wee Family Control: Controls both Haw Par and UOB - no incentive to unlock value
- No Activist Pressure: Singapore governance tolerates cross-holdings
- Boring Business: Tiger Balm is small and mature
- Historical Pattern: Discount has existed for 20+ years
What could unlock value:
- Family generational transition (speculative)
- UOB dividend increases flowing to Haw Par
- Bank stock re-rating lifting portfolio value
- Tiger Balm sale to strategic buyer (unlikely)
Sum-of-Parts Valuation
| Component | Value/Share |
|---|---|
| UOB + UOL stakes | ~S$11.70 |
| Net cash | S$3.31 |
| Tiger Balm (10x EBIT) | ~S$4.50 |
| SOTP Value | ~S$19.50 |
| Current Price | S$15.18 |
| Discount to SOTP | 22% |
Entry Prices
| Level | Price | Discount to SOTP |
|---|---|---|
| Strong Buy | S$12.50 | 36% |
| Accumulate | S$14.00 | 28% |
| Fair Value | S$15.00 | 23% |
| Current | S$15.18 | 22% |
Risks
| Risk | Severity | Assessment |
|---|---|---|
| Value trap persistence | HIGH | 20+ years of discount |
| UOB correlation | MEDIUM | Bank weakness = Haw Par weakness |
| Brand erosion | LOW | Tiger Balm stable but mature |
| Governance | MEDIUM | No minority shareholder catalysts |
Verdict: WAIT
Haw Par trades at a 22% discount to sum-of-parts with no catalyst to close the gap. The recent +36% rally was driven by Singapore bank strength (UOB near ATH).
Investment thesis:
- This is a "cigar butt" investment - there's value here, but no urgency
- Wait for S$12.50-14.00 during market weakness
- The asymmetric opportunity is if Singapore banks correct 20%+ (Haw Par would fall more than its underlying value loss)
Quality Grade: B+ - Solid brand, hidden assets, but value trap dynamics